Apeloa Pharmaceutical Co.,Ltd
000739
Rank in Stocks
#4305
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Share Price
$3.17
Market Cap
$3.67B
Change (1 day)
0.76%
Change (1 year)
40.57%
Country
CN
Trade Apeloa Pharmaceutical Co.,Ltd (000739)
Category
Healthcare
P/S ratio for Apeloa Pharmaceutical Co.,Ltd (000739)
P/S ratio as of October 2026 TTM: 3.02
According to Apeloa Pharmaceutical Co.,Ltd latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.02. At the end of 2023 the company had a P/S ratio of 1.58.
P/S ratio history for Apeloa Pharmaceutical Co.,Ltd from 2000 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 3.02 | 92.23% |
| 2024 | 1.57 | -0.75% |
| 2023 | 1.58 | -33.91% |
| 2022 | 2.39 | -48.35% |
| 2021 | 4.62 | 32.81% |
| 2020 | 3.48 | 64.26% |
| 2019 | 2.12 | 54.78% |
| 2018 | 1.37 | 1.75% |
| 2017 | 1.35 | -25.37% |
| 2016 | 1.80 | -16.80% |
| 2015 | 2.17 | 10.98% |
| 2014 | 1.95 | 91.95% |
| 2013 | 1.02 | 118.48% |
| 2012 | 0.47 | -78.84% |
| 2011 | 2.20 | 42.46% |
| 2010 | 1.55 | -17.73% |
| 2009 | 1.88 | 119.94% |
| 2008 | 0.85 | -67.41% |
| 2007 | 2.62 | 128.30% |
| 2006 | 1.15 | 105.61% |
| 2005 | 0.56 | -31.73% |
| 2004 | 0.82 | -9.78% |
| 2003 | 0.91 | -43.62% |
| 2002 | 1.61 | -86.69% |
| 2001 | 12.08 | 16.98% |
| 2000 | 10.33 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 133.86% |
IN
|
